Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Review time for a new drug in Japan has shortened dramatically since the establishment of the Pharmaceuticals and Medical Devices Agency (PMDA). Nonetheless, Japan faces a new challenge so-called "Drug Loss", which means that new drugs approved overseas have not yet been developed in Japan or that development is delayed. In this manuscript, we describe how PMDA facilitates Japan's drug development to continuously provide innovative drugs to patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/cpt.70022 | DOI Listing |
Publication Analysis
Top Keywords
drug development
8
expediting drug
4
japan
4
development japan
4
japan pmda
4
pmda perspective
4
perspective review
4
review time
4
time drug
4
drug japan
4